GSK, Teva To Take Lamictal Pay-For-Delay Case To High Court
GlaxoSmithKline and Teva told a New Jersey federal court on Monday that they plan to ask the U.S. Supreme Court to review whether a pay-for-delay class action against them should be...To view the full article, register now.
Already a subscriber? Click here to view full article